You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 19, 2025

Alpharma Us Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ALPHARMA US PHARMS, and what generic and branded alternatives to ALPHARMA US PHARMS drugs are available?

ALPHARMA US PHARMS has sixty-one approved drugs.

Summary for Alpharma Us Pharms

US Patents:	0
Tradenames:	43
Ingredients:	40
NDAs:	61

Drugs and US Patents for Alpharma Us Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alpharma Us Pharms	PIPERAZINE CITRATE	piperazine citrate	SYRUP;ORAL	080774-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Alpharma Us Pharms	BETAMETHASONE DIPROPIONATE	betamethasone dipropionate	LOTION;TOPICAL	071085-001	Feb 3, 1987		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Alpharma Us Pharms	ERYTHROMYCIN	erythromycin	SOLUTION;TOPICAL	062326-001	Apr 19, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Alpharma Us Pharms	TRIAMCINOLONE ACETONIDE	triamcinolone acetonide	LOTION;TOPICAL	087191-001	Sep 8, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Alpharma Us Pharms	ERYTHROMYCIN ETHYLSUCCINATE	erythromycin ethylsuccinate	SUSPENSION;ORAL	062200-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Alpharma Us Pharms	MYKINAC	nystatin	CREAM;TOPICAL	062387-001	Jul 29, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-004	Approved Prior to Jan 1, 1982		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Alpharma Us Pharms

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-002	Approved Prior to Jan 1, 1982	4,620,974	⤷ Subscribe
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-004	Approved Prior to Jan 1, 1982	4,620,974	⤷ Subscribe
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-006	Approved Prior to Jan 1, 1982	4,620,974	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.